Airfinity Ltd
Arsalan A. has a diverse work experience, starting with their role as a Research Assistant at the University of Oxford in 2012. Arsalan then moved on to work as a Postdoctoral Fellow at the University of Cambridge from June 2018 to October 2020. Following that, they joined Airfinity Ltd in October 2020 as a Senior Analyst and later took on the role of Head of Treatments from September 2021 to May 2023. Currently, they hold the position of Senior Director of Custom & Strategic Analysis at Airfinity Ltd, which they started in May 2023.
Arsalan A. completed their Doctor of Philosophy (PhD) in Molecular Biology from the University of Cambridge in 2018. Prior to that, they pursued a Master of Science (MS) in Radiation Oncology and Biology from the University of Oxford from 2011 to 2012. Before joining Oxford, Arsalan obtained their Bachelor's degree in Biology, General from the University of Nottingham, where they studied from 2008 to 2011. Their educational journey began at Greenwood Dale, where they completed their previous qualifications before entering university, during the period from 2001 to 2008.
This person is not in any offices
Airfinity Ltd
Airfinity is a pioneer in predictive health analytics that decision makers can trust, understand and act on to preempt future health risks.Specialising in infectious diseases, Airfinity has a comprehensive suite of world-leading market intelligence solutions, turning disconnected data points into real time predictive indicators. The platform alsocovers advanced therapies (e.g. RNA, Gene and Cell Therapy) and cardio-metabolic.Disease-centric solutions combine proprietary surveillance tools and forecast models with expert analysis to produce actionable insights on pipeline developments, standard of care, regulatory trends and demand and supply.Airfinity is a global company with headquarters in London and Boston, relied upon across the full ecosystem in life sciences, including pharma companies, government agencies, corporates, investors, NGOs, and international organisations.